Functionalized biocompatible WO<inf>3</inf> nanoparticles for triggered and targeted in vitro and in vivo photothermal therapy
- Authors
- Sharker S.M.[Sharker S.M.]; Kim S.M.[Kim S.M.]; Lee J.E.[Lee J.E.]; Choi K.H.[Choi K.H.]; Shin G.[Shin G.]; Lee S.[Lee S.]; Lee K.D.[Lee K.D.]; Jeong J.H.[Jeong J.H.]; Lee H.[Lee H.]; Park S.Y.[Park S.Y.]
- Issue Date
- 2015
- Keywords
- WO3; Hyaluronic acid; Biocompatibility; Target delivery; Photothermal therapy
- Citation
- Journal of Controlled Release, v.217, pp.211 - 220
- Journal Title
- Journal of Controlled Release
- Volume
- 217
- Start Page
- 211
- End Page
- 220
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/48935
- DOI
- 10.1016/j.jconrel.2015.09.010
- Abstract
- We report on dopamine-conjugated hyaluronic acid (HA-D), a mussel-inspired facile capping material that can modify tungsten oxide (WO<inf>3</inf>) nanoparticles to be both biocompatible and targetable, allowing precise delivery (WO<inf>3</inf>-HA) to a tumor site. Near-infrared (NIR) irradiated WO<inf>3</inf>-HA showed a rapid and substantial rise in photothermal heat to complete in vitro thermolysis of malignant MDAMB and A549 cancer cellsbut was found to be relatively less sensitive to normal MDCK cells. A long-term in vivo investigation of ~10 nm HA thickness on WO<inf>3</inf> (WO<inf>3</inf>-HA) nanoparticles demonstrated efficient photo-thermal conversion with time-dependent tumor target accumulation. This long-term in vivo survival study ofWO<inf>3</inf>-HA showed promising biocompatibility with a complete recovery from malignant tumor. Due to the importance of keeping simplicity in the design of therapeutic nanoparticles, we therefore expect that this facile scheme (HA-D) would contribute to the biocompatible development of versatile metallic nanoparticles for photothermal applications. © 2015 Published by Elsevier B.V.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Pharmacy > Department of Pharmacy > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.